The patient is ordered Glucerna 1.2 calories. You're supplied with a can of Glucerna that contains 237 mL. The doctor orders the tube feeding to be administered at a 1/2 strength with a rate of 65 mL/hr. How much water will you add to dilute the tube feeding formula as prescribed?

A) Infections become resistant to high doses of antibiotics:
Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of Staphylococcus aureus that has become resistant to the antibiotic methicillin, as well as other beta-lactam antibiotics (such as penicillin and cephalosporins). Over time, bacteria can develop resistance mechanisms, often as a result of antibiotic misuse or overuse, such as not completing a full course of treatment or using antibiotics unnecessarily. MRSA, in particular, can grow resistant to higher and higher doses of standard antibiotics, making treatment more challenging.

B) Antibiotic dosages below the minimum concentration are prescribed:
Antibiotic dosages should always be prescribed at the minimum inhibitory concentration (MIC), which is the lowest concentration of the drug that can inhibit bacterial growth. Prescribing antibiotics below this concentration would not be effective in treating the infection and could contribute to antibiotic resistance.

C) Antibiotics are prescribed only when a viral infection is present:
Antibiotics, including those prescribed for MRSA, are only effective against bacterial infections, not viral infections. For viral infections (such as the flu or common cold), antibiotics should not be used, as they are ineffective. MRSA is a bacterial infection, and it requires appropriate antibiotic therapy specifically targeted to the bacteria, not a viral infection.

D) Broad-spectrum antibiotics are used whenever possible:
While broad-spectrum antibiotics are sometimes used in initial treatments when the specific bacterial pathogen is unknown, their overuse can contribute to the development of antibiotic resistance. In the case of MRSA, a more targeted approach with antibiotics specifically effective against resistant strains (like vancomycin or clindamycin) is preferred.

A) Naloxone (Narcan):
Naloxone is the antidote for opioid overdose, not for digoxin toxicity. It works by reversing the effects of opioid drugs such as morphine, heroin, and oxycodone by binding to opioid receptors in the brain. While Naloxone is vital in opioid toxicity, it has no effect on the toxicity of digoxin.

B) Digoxin immune FAB (Digibind):
Digoxin immune FAB (Digibind) is the antidote for digoxin toxicity. It works by binding to the digoxin molecules in the bloodstream, thereby inactivating them and preventing them from exerting their toxic effects on the heart. This treatment is critical in cases of severe digoxin toxicity, particularly when the patient exhibits symptoms such as life-threatening arrhythmias, severe bradycardia, or altered mental status.

C) Vitamin K:
Vitamin K is the antidote for warfarin (Coumadin) toxicity, not digoxin toxicity. It promotes the synthesis of clotting factors in the liver and is used to reverse excessive anticoagulation in cases of bleeding due to warfarin. It has no effect on digoxin toxicity, which requires specific treatment with digoxin immune FAB.

D) Inamrinone (Inocor):
Inamrinone is an inotropic medication used to treat severe heart failure by improving heart contractility. However, it is not used as an antidote for digoxin toxicity. In fact, inamrinone and other inotropic agents may be used cautiously in patients with digoxin toxicity, as they could potentially exacerbate arrhythmias, a known complication of digoxin toxicity.